192 related articles for article (PubMed ID: 23897439)
41. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
Kinzler I; Haseroth E; Hauser C; Rück A
Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
[TBL] [Abstract][Full Text] [Related]
42. Luminol Chemiluminescence Reports Photodynamic Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic Efficacy.
Davis RW; Snyder E; Miller J; Carter S; Houser C; Klampatsa A; Albelda SM; Cengel KA; Busch TM
Photochem Photobiol; 2019 Jan; 95(1):430-438. PubMed ID: 30357853
[TBL] [Abstract][Full Text] [Related]
43. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
[TBL] [Abstract][Full Text] [Related]
44. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
45. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
[TBL] [Abstract][Full Text] [Related]
46. Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
Bellnier DA; Henderson BW; Pandey RK; Potter WR; Dougherty TJ
J Photochem Photobiol B; 1993 Sep; 20(1):55-61. PubMed ID: 8229470
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.
Hajri A; Wack S; Meyer C; Smith MK; Leberquier C; Kedinger M; Aprahamian M
Photochem Photobiol; 2002 Feb; 75(2):140-8. PubMed ID: 11883602
[TBL] [Abstract][Full Text] [Related]
48. The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.
Yang PW; Hung MC; Hsieh CY; Tung EC; Wang YH; Tsai JC; Lee JM
Lasers Med Sci; 2013 Feb; 28(2):605-14. PubMed ID: 22585382
[TBL] [Abstract][Full Text] [Related]
49. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.
Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM
Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615
[TBL] [Abstract][Full Text] [Related]
50. Photodynamic therapy induces an immune response against a bacterial pathogen.
Huang YY; Tanaka M; Vecchio D; Garcia-Diaz M; Chang J; Morimoto Y; Hamblin MR
Expert Rev Clin Immunol; 2012 Jul; 8(5):479-94. PubMed ID: 22882222
[TBL] [Abstract][Full Text] [Related]
51. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
52. Deposition of complement proteins on cells treated by photodynamic therapy in vitro.
Cecic I; Korbelik M
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):189-203. PubMed ID: 16566717
[TBL] [Abstract][Full Text] [Related]
53. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas.
Cincotta L; Foley JW; MacEachern T; Lampros E; Cincotta AH
Cancer Res; 1994 Mar; 54(5):1249-58. PubMed ID: 8118813
[TBL] [Abstract][Full Text] [Related]
54. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
[TBL] [Abstract][Full Text] [Related]
55. PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
Ong YH; Kim MM; Finlay JC; Dimofte A; Singhal S; Glatstein E; Cengel KA; Zhu TC
Phys Med Biol; 2017 Dec; 63(1):015031. PubMed ID: 29106380
[TBL] [Abstract][Full Text] [Related]
56. Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).
James NS; Joshi P; Ohulchanskyy TY; Chen Y; Tabaczynski W; Durrani F; Shibata M; Pandey RK
Eur J Med Chem; 2016 Oct; 122():770-785. PubMed ID: 27543778
[TBL] [Abstract][Full Text] [Related]
57. Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes.
Yu X; Gao D; Gao L; Lai J; Zhang C; Zhao Y; Zhong L; Jia B; Wang F; Chen X; Liu Z
ACS Nano; 2017 Oct; 11(10):10147-10158. PubMed ID: 28901740
[TBL] [Abstract][Full Text] [Related]
58. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry.
Georgakoudi I; Nichols MG; Foster TH
Photochem Photobiol; 1997 Jan; 65(1):135-44. PubMed ID: 9066293
[TBL] [Abstract][Full Text] [Related]
59. Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic cancer cells
Shen YJ; Cao J; Sun F; Cai XL; Li MM; Zheng NN; Qu CY; Zhang Y; Shen F; Zhou M; Chen YW; Xu LM
World J Gastroenterol; 2018 Dec; 24(46):5246-5258. PubMed ID: 30581273
[TBL] [Abstract][Full Text] [Related]
60. The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy.
Reeves KJ; Reed MW; Brown NJ
J Photochem Photobiol B; 2010 Dec; 101(3):224-32. PubMed ID: 20724176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
